InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1 |
VJJPUSNTGOMMGY-MRVIYFEKSA-N |
[H][C@]12COC(=O)[C@]1([H])[C@H](c1cc(OC)c(O)c(OC)c1)c1cc3OCOc3cc1[C@H]2O[C@@H]1O[C@@H]2CO[C@@H](C)O[C@H]2[C@H](O)[C@H]1O |
|
DNA synthesis inhibitor
Any substance that inhibits the synthesis of DNA.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-β-D-glucopyranoside
|
etoposide
|
ChemIDplus
|
Etoposido
|
ChemIDplus
|
etoposidum
|
ChemIDplus
|
(−)-etoposide
|
DrugBank
|
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
|
ChemIDplus
|
4-demethylepipodophyllotoxin β-D-ethylideneglucoside
|
ChemIDplus
|
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one
|
ChemIDplus
|
Etoposide
|
KEGG COMPOUND
|
trans-Etoposide
|
DrugBank
|
VP-16
|
KEGG COMPOUND
|
Eposin
|
DrugBank
|
Etopophos
|
DrugBank
|
Lastet
|
DrugBank
|
Toposar
|
DrugBank
|
Vepesid
|
DrugBank
|
1112
|
DrugCentral
|
C01576
|
KEGG COMPOUND
|
D00125
|
KEGG DRUG
|
DB00773
|
DrugBank
|
Etoposide
|
Wikipedia
|
LSM-6348
|
LINCS
|
US3524844
|
Patent
|
View more database links |
33419-42-0
|
CAS Registry Number
|
KEGG COMPOUND
|
33419-42-0
|
CAS Registry Number
|
ChemIDplus
|
|